Intuitive's E-100 generator is its first internally developed robotic generator to power two key instruments on the da Vinci X and Xi systems. Vessel Sealer Extend is the flagship instrument in the da Vinci energy sealing portfolio today, and the new SynchroSeal instrument offers enhanced capabilities1 in general surgery.
We are pleased to receive FDA clearance, providing surgeons an additional tool for the X and
The E-100 is Intuitive's first generator and is offered as an upgrade to power Vessel Sealer Extend and SynchroSeal. SynchroSeal will enable a surgeon to perform rapid1 one-step sealing and transection with a single pedal press.
SynchroSeal uses advanced bipolar energy from its raised cut electrode to transect tissue then cool down quickly2, and will allow surgeons to move on to the next step. With its wristed articulation, its rapid sealing cycle, and refined curved jaw, SynchroSeal offers enhanced versatility to the da Vinci Energy portfolio1.
Compared to Vessel Sealer Extend on Erbe VIO dV
Data on file
About Intuitive
Intuitive brings more than two decades of leadership in robotic-assisted surgical technology and solutions to its offerings, and develops, manufactures and markets the da Vinci surgical system and the Ion endoluminal system.
About the da Vinci Surgical System
There are several models of the da Vinci surgical system. The da Vinci surgical systems are designed to help surgeons perform minimally invasive surgery.
Forward Looking Statements
This press release contains forward-looking statements, including statements regarding the performance of the company's products. These forward-looking statements are based on current expectations and estimates and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including, but not limited to the risk factors under the heading 'Risk Factors' in the company's annual report on Form 10-K for the year ended
Contact:
Tel: +1-408-523-7337
Email: corp.comm@intusurg.com
(C) 2019 Electronic News Publishing, source